Method for the validation of immunohistochemical staining using SCID mouse xenografts: Expression of CD40 and CD154 in human non-small cell lung cancer

Oncology Reports

Volumn 29, Issue 4, 2013, Pages 1315-1321

  Ishikawa, Keidai ^a   Miyamoto, Masaki ^a   Yoshioka, Tatsuya ^a   Kadoya, Masatoshi ^a   Li, Li ^a   Mishra, Roshan ^a   Ichinokawa, Kazuomi ^a   Shoji, Yasuhito ^a   Matsumura, Yoshiyuki ^a   Hida, Yasuhiro ^a   Kaga, Kichizo ^a   Kato, Tatsuya ^a,b   Kaji, Mitsuhito ^b   Ohbuchi, Toshiro ^c   Itoh, Tomoo ^d   Dosaka Akita, Hirotoshi ^a   Matsui, Yoshiro ^a   Hirano, Satoshi ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Sapporo Minami Sanjo Hospital   (Japan)

^c Minami ichijo Hospital   (Japan)

^d KOBE UNIVERSITY HOSPITAL   (Japan)

Author keywords

CD154; CD40; Immunohistochemistry; Lung cancer; Positive control; Xenograft

Indexed keywords

ANTIBODY; CD40 ANTIGEN; CD40 LIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; CELL LINE; CELL STRAIN LK2; CELL STRAIN PC10; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; SENSITIVITY AND SPECIFICITY; STANDARDIZATION; TUMOR XENOGRAFT; VALIDATION PROCESS; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ANTIGENS, CD40; CARCINOMA, NON-SMALL-CELL LUNG; CD40 LIGAND; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MICE; MICE, SCID; STAINING AND LABELING; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84874719867     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2013.2275     Document Type: Article

References (25)

1. Banchereau J, Bazan F, Blanchard D, et al: The CD40 antigen and its ligand. Annu Rev Immunol 12: 881-922, 1994.
2. Smith CA, Farrah T and Goodwin RG: The TNF receptor super¬family of cellular and viral proteins: activation, costimulation, and death. Cell 76: 959-962, 1994.
3. Paulie S, Ehlin-Henriksson B, Mellstedt H, Koho H, Ben-Aissa H and Perlman BA: p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes. Cancer Immunol Immunother 20: 23-28, 1985.
4. Aldderson MR, Armitage R, Tough TW, Strockbine L, Fanslow WC and Spriggs M: CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD4. Exp Med 178: 669-674, 1993.
5. Caux C, Massacrier C, Vanbervliet B, et al: Activation of human dendritic cells through CD40 cross-linking. J Exp Med 180: 1263-1272, 1994.
6. Yellin MJ, Winikoff S, Fortune SM, et al: Ligation of CD40 on fibroblast induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation. J Leukocyt Biol 58: 209-216, 1995.
7. Zong YS, Lin H, Choy DTK, et al: Nasopharyngeal carcinoma and lymphoinfiltration. Oncology 48: 290-296, 1991.
8. Galy AHM and Spitz H: CD40 is functionally expressed on human thymic epithelial cells. J Immunol 149: 775-782, 1992.
9. Pammer J, Weninger W, Mazal PR, Horvat R and Tschachler E: Expression of the CD40 antigen on normal endothelial cells and in benign and malignant tumours of vascular origin. Histopathology 29: 517-524, 1996.
10. Armitage RJ, Fanslow WC, Stockbine L, et al: Molecular and biological characterization of a murine ligand for CD40. Nature 357: 80-82, 1992.
11. Gauchat JF, Henchoz S, Mazzei G, et al: Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 365: 340-343, 1993.
12. Banchereau J, de Paoli P, Valle A, et al: Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 251: 70-72, 1991.
13. Liu YJ, Mason DY, Johnson GD, et al: Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur J Immunol 21: 1905-1910, 1991.
14. Choi MSK, Boise LH, Gottschalk AR, Quintans J, Thompson CB and Klaus GGB: The role of bcl-xl-mediated rescue from anti-induced apoptosis in WEHI-231 B lymphoma cells. Eur J Immunol 25: 1352-1357, 1995.
15. Ludewig B, Graf D, Gelderblom HR, Becker Y, Kroczek RA and Pauli G: Spontaneous apoptosis of dendritic cells is efficiency inhibited by TRAP (CD40-ligand) and TNF-a, but strongly enhanced by interleukin-10. Eur J Immunol 25: 1943-1950, 1995.
16. Tong AW, Papayoti MH, Netto G, et al: Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer. Clin Cancer Res 3: 691-703, 2001.
17. Costello A, Rey-Hipolito C, Patel A, et al: Thyroid cancers express CD-40 and CD-40 ligand: cancers that express CD-40 ligand may have a greater risk of recurrence in young patients. Thyroid 2: 105-113, 2005.
18. Campean V, Neureiter D, Nonnast-Daniel B, Garlichs C, Gross ML and Amann K: CD40-CD154 expression in calcified and non calcified coronary lesions of patients with chronic renal failure. Atherosclerosis 190: 155-166, 2007.
19. Yamada M, Shiroko T, Kawaguchi Y, et al: CD40-CD40 ligand (CD154) engagement is required but not sufficient for modulating MHC class I, ICAM-1 and Fas expression and proliferation of human non-small cell lung tumors. Int J Cancer 92: 589-599, 2001.
20. Ishikawa K, Miyamoto M, Yoshioka T, et al: Up-regulation of CD40 with juxtacrine activity in human nonsmall lung cancer cells correlates with poor prognosis. Cancer 113: 530-541, 2008.
21. Bajorath J, Seyama K, Nonoyama S, Ochs HD and Aruffo A: Classification of mutations in the human CD40 ligand, gp39, that is associated with X-linked hyper IgM syndrome. Protein Sci 5: 531-534, 1996.
22. Fujimoto T, Nakamura T, Nishimura Y, et al: Up-regulation of interleukin-12 receptor expression in peripheral blood mono¬nuclear cells of patients with HTLV-I-associated myelopathy/tropical spastic paraparesis. J Neurol Sci 196: 21-26, 2002.
23. Balashov KE, Smith DR, Khoury SJ, Hafler DA and Weiner HL: Increased interleukin 12 production in progressive multiple sclerosis: Induction by activated CD4+ T cells via CD40 ligand. Proc Natl Acad Sci USA 94: 599-603, 1997.
24. Eriksson T, Frisk T, Gray SG, et al: Methylation changes in the human IGF2 p3 promoter parallel IGF2 expression in the primary tumor, established cell line, and xenograft of a human hepatoblastoma. Exp Cell Res 270: 88-95, 2001.
25. Hellings PW, Kasran A, Bullens D, et al: IL-10-and IL-12-independent down-regulation of allergic sensitization by stimulation of CD40 signaling. J Immunol 177: 5138-5144, 2006.